BRD2 and Mental deterioration: It is possible therefore that FSH blockade in the early years of the menopause may, in fact, reduce the extent of bone loss, visceral obesity, energy dysregulation, and the spikes of cognitive decline that are noted as early as the late perimenopause, when, as stated above, serum FSH levels are rising in the face of normal estrogen as a response to declining ovarian reserve.